EP Patent

EP3024463B1 — Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders

Assigned to Neuren Pharmaceuticals Ltd New Zealand · Expires 2020-03-25 · 6y expired

What this patent protects

Patent listed against fenfluramine-hydrochloride.

Drugs covered by this patent

fenfluramine-hydrochloride (FENFLURAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3024463B1
Jurisdiction: EP
Classification: —
Expires: 2020-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Neuren Pharmaceuticals Ltd New Zealand
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.